Population Health
Breast Suite
AI-powered breast cancer detection
Enhanced efficiency and accuracy in breast cancer detection
Breast Suite in an AI-powered, end-to-end suite of modular, interoperable applications that are designed to seamlessly integrate into existing breast cancer diagnostic workflows and technology, significantly improving diagnostic accuracy, workflow efficiency and standardization of care.
Built on DeepHealth's cloud-native platform, applications integrate seamlessly with existing customer technology, offer secure remote access, and ensure a unified, standardized clinical experience.
"It has made me considerably more efficient due to decreased lag between loading patient studies, in particular as it relates to breast tomography where I can instantly review the current study along with multiple prior exams."
Jason R. Sinner M.D.
Medical Director, RadNet/BRMG
"Breast Suite applications help me read smarter and more efficiently. It allows me to sort and prioritize mammograms most likely to have cancer in them and draws my attention to what really matters in each image."
Dr. Jacquline Holt
Medical Director, Women’s Imaging, Delaware Imaging Network, RadNet
AI-powered Safeguard Review
Improve cancer detection rates with second reviewer workflow
DM (2D)
DBT (3D)
Breast Suite
Clinical Impact at Scale
More cancers detected
21%
Increased CDR2
Superior accuracy
Algorithm
trained on more than a million views, 300,000
total exams, and 34,000 biopsy proven cancer
Benefits across diverse populations
23%
More cancers detected in
women with dense breasts2
20%
More cancers detected in
Black/African American women2
Increased productivity and operational efficiency
Specialist level care
Achieved
by a group of radiologists3
AI-powered workflow
With smart
alerts to prioritize exam review and intelligent worklist sorting
Proven success in 230+ screening sites
RadNet's breast screening program is a breakthrough in detection.
It is powered by DeepHealth solutions, including components of Breast Suite.
Combined with exceptionally high-quality mammography systems, RadNet's breast screening program optimizes breast cancer screening workflow, giving women greater confidence in their results.
Transforming population health with AI-powered diagnostic screening programs
Explore our visionCould healthcare begin before illness ever shows up? Rather than waiting for patients to experience symptoms, what if care started with prevention, early detection, and access to critical diagnostic tools?
Finding and treating diseases, like cancer, at earlier stages increases survival rates.4 Screening healthy people helps make early detection more possible. By expanding screening for a range of diseases, more people have the chance to stay healthy longer—and this shift has the potential to significantly transform population health.
Population Health Suite of Solutions
Orchestrate and scale high-volume cancer screening and disease assessment programs.
Find out moreLearn more
2025 Society of Breast Imaging(SBI) - Breast Imaging Symposium
Meet DeepHealth at SBI 2025 and discover SmartMammo™, our AI-powered breast cancer detection solution for greater accuracy and precision in mammogram interpretation. We’re proud to join the SBI community in celebrating the Society’s 40th anniversary with a rich and forward-looking program.
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
November 11, 2024: Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging.
RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
Somerville, MA, November 29, 2024 – DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo1, is now FDA-cleared to be compatible with GE HealthCare’s Senographe Pristina™ mammography systems.
Disclaimers: Breast Suite comprises multiple applications including ProFound Pro, Breast Density, Risk Assessment, BAC and DeepHealth Viewer. DeepHealth Viewer is manufactured byeRAD and distributed by DeepHealth. Any claims made about Breast Suite may reference claims associated with its individual components. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us